Kynam Capital Management sold 1,059,375 shares of CG Oncology (CGON) in Q4, reducing its stake to 2.51% of its reportable assets under management. The divestment totals $43.8 million in shares.
Kynam Capital Reduces CG Oncology (CGON) Stake by $43.8 Million
|1 min read
CGONInstitutional SellingHedge FundsBiotechnologyFund Holdings
